{
    "2021-01-27": [
        [
            {
                "time": "",
                "original_text": "生物医药行业深度报告：长期看好港股医药优质细分领域龙头",
                "features": {
                    "keywords": [
                        "生物医药",
                        "港股",
                        "医药",
                        "优质细分领域",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德(02359)子公司认购1.1亿元私募基金份额",
                "features": {
                    "keywords": [
                        "药明康德",
                        "子公司",
                        "私募基金",
                        "认购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【中金医药】2020年报业绩预览 - 中金医药周报（勘误）",
                "features": {
                    "keywords": [
                        "中金医药",
                        "年报",
                        "业绩预览"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "药明康德现1笔大宗交易 共成交930.88万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：药明一期拟认购珠海通和毓承三期投资合伙企业1.1亿元份额",
                "features": {
                    "keywords": [
                        "药明康德",
                        "珠海通和毓承",
                        "投资",
                        "认购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万联证券 - CRO行业深度报告：创新药大时代，CRO乘风起舞【行业研究】",
                "features": {
                    "keywords": [
                        "CRO",
                        "创新药",
                        "行业研究"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "今日上市ETF | 首只跟踪生物科技主题指数的ETF来了！上市规模达28亿元，重仓药明康德、迈瑞和恒瑞",
                "features": {
                    "keywords": [
                        "ETF",
                        "生物科技",
                        "药明康德",
                        "迈瑞",
                        "恒瑞"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：20年收入持续提速 实验室业务拉动整体毛利提升",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "收入增长",
                        "实验室业务",
                        "毛利提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "1年狂涨20倍！最强牛股宣布盈利猛增40倍，股价就崩了",
                "features": {
                    "keywords": [
                        "牛股",
                        "盈利增长",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：略超预期 看好新产能 平台化加速节奏",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "新产能",
                        "平台化",
                        "加速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "掘金龙虎榜 54股近期获机构净买入",
                "features": {
                    "keywords": [
                        "龙虎榜",
                        "机构净买入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信建投：节前看好年报行情及疫情受益主线",
                "features": {
                    "keywords": [
                        "中信建投",
                        "年报行情",
                        "疫情受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}